Michele Nadeem-Baker's Video Blog Update

Published on

Topics include: Patient Stories and Treatments

On location in Boston, Patient Power Founder and Host, Andrew Schorr, and Patient Power Correspondent, Michele Nadeem-Baker, discuss the Dana-Farber Cancer Institute FCR+ibrutinib clinical trial in which Michele is participating.  She is very close to achieving MRD negativity and attributes this and her positive outlook for the future to her participation in the clinical trial.  “It kept me alive, and will keep me alive!” exclaims Michele.  

View more programs featuring and

Related Programs

A Patient Power Team Member Shares Her Clinical Trial Experience

Patient Power contributor and CLL patient Michele Nadeem-Baker shares the first of a series of personal video blogs as she reports on her progress in a CLL clinical trial at the Dana-Farber Cancer Institute in Boston, Mass.

Published:

A Patient Power Team Member's Clinical Trial Video Diary: Month 2

Patient Power contributor Michele Nadeem, on location at the Dana-Faber Cancer Institute, shares a video health update as she enters month two of the clinical trial she is participating in.

Published:

Michele Nadeem-Baker's Video Blog: Month 3

Patient Power contributor and CLL patient, Michele Nadeem-Baker, blogs about her FCR/ibrutinib combination therapy clinical trial at Dana-Farber Cancer Institute.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on July 29, 2016